Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Alcidion Group Limited ( (AU:ALC) ) has issued an update.
Alcidion Group Limited announced its upcoming release of the Q2 FY25 Appendix 4C Quarterly Cash Flow Report, scheduled for January 30, 2025. The company will host a live webcast to discuss the quarter’s operational and commercial highlights. This announcement highlights Alcidion’s continued transparency and engagement with investors, reflecting its strong position in the healthcare technology industry and potential future growth.
More about Alcidion Group Limited
Alcidion Group Limited is a healthcare technology company dedicated to transforming healthcare with smart, proactive, and intuitive solutions that enhance patient care efficiency and quality. The company’s flagship product, Miya Precision, offers clinical decision support, communication facilitation, and task management to healthcare organizations globally. Since its ASX listing in 2011, Alcidion has expanded its reach to over 400 hospitals and 87 healthcare organizations in the UK, Australia, and New Zealand, with plans for further geographical growth.
YTD Price Performance: 10.0%
Average Trading Volume: 907,831
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$88.63M
See more insights into ALC stock on TipRanks’ Stock Analysis page.
